| CHAMPIONS ONCOLOGY DL-,01 |
| USA |
| Gesundheit |
| US15870P3073 / A14X6S |
| 2I3 (Frankfurt) / CSBR (NASDAQ) |
| FRA:2I3, ETR:2I3, 2I3:GR, NASDAQ:CSBR |
| - |
| https://www.championsonco.. |
|
Champions Oncology, Inc. operates as a biotechnology company with a core focus on developing advanced technologies and research models to enhance drug discovery and therapeutic applications in oncology. The primary function of Champions Oncology is t..
>Volltext.. |
| 74.3 Mio. EUR |
| 72.52 Mio. EUR |
| 50.82 Mio. EUR |
| -0.68 Mio. EUR |
| -2 Mio. EUR |
| -0.15 EUR |
| 4.38 Mio. EUR |
| 6.25 Mio. EUR |
| 3.85 Mio. EUR |
| 0.34 |
| -1.1% |
| -135.51% |
| - |
| - |
| - |
| - |
| CHAMPIONS ONCOLOGY |
| 22.07.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|